SOUL, MEDI-FUTURE’s brand-new Digital Mammography that was launched 

last month, received favorable reviews in the European market

As soon as SOUL was introduced to the market in Europe, a deal for 10 units got closed last week, 

and the export of the units will be completed during the month of June.

In addition, MEDI-FUTURE and MIS Healthcare, a U.K. partner, agreed with each other

 to launch SOUL in U.K. in May. At the same time, MEDI-FUTURE planned to participate

 in the U.K. Breast Cancer Symposium in June to start full-scale promotion.

Due to these circumstances, the superior quality of SOUL was once again proved.

These favorable reviews are expected to be a powerful spur to MEDI-FUTURE’s 

expanding its European market share.

 MEDI-FUTURE is a global healthcare IT company dedicated to women's breast care.

 Create Women's Health and Beauty